More New EMA Guidance Qualification of novel Methodologies for Drug Development
More Health Commissioner welcomes Agreement on the Revision of EU Rules on Clinical Trials
More 85 Company listed with GMP-Non Compliance Statements in the New EMA Database
More "Reception denied!" - the new FDA "Refuse-to-Receive" Guidance for Generics Applications
More Update: Electronic Submission of Marketing Authorisation Dossiers
More Implementation of Good Distribution Practices: Explanatory Notes from MHRA
More EMA now also issues GMP and GDP Non-Compliance Information
More USP proposal on temperature control during storage and distribution